SEC Form 4 · accession 0001513162-15-000188
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis H Titterton Jr.
Director
Period of report
Apr 1, 2015
Accepted (ET)
Apr 6, 2015 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 1, 2015 | P | 20,000 | $0.14 | A | 11,244,025 | D | |
| Common Stock | Apr 2, 2015 | P | 10,000 | $0.164 | A | 11,254,025 | D |
Table II — derivative securities
No Table II lines on this filing.